NICE Recommends Kuvan to Treat Children 18 and Younger

NICE Recommends Kuvan to Treat Children 18 and Younger

288599

NICE Recommends Kuvan to Treat Children 18 and Younger

The National Institute for Health and Care Excellence (NICE) has issued draft guidance that recommends Kuvan (sapropterin), alongside a low-phenylalanine diet, for treating children younger than 18 who have  phenylketonuria (PKU). NICE estimates that about 75 children with PKU in England would be eligible for treatment, out of a total eligible population of about 308 people. The draft guidance is open for comments through March 16. The committee will meet to consider the responses on April…

You must be logged in to read/download the full post.